INS and Hyperglycemia: Current therapeutic strategies to manage hyperglycemia do not halt (or reverse) disease progression and may even cause undesirable adverse effects and comorbidities on their own [83], while treatment with insulin, sulfonylureas, and glinides may lead to weight gain [84].